Candidate ESCC antigens, NLRC5, LCP2, TMEM229B, and FCRL4, were selected after screening; upregulation of the antigens is associated with poor prognosis, high infiltration of APCs, and high level of MHC class II gene expression. Here, FCRL4 is linked to esophageal squamous cell carcinoma.